← All trials
NCT05375630
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 21, 2022
- Primary completion
- Oct 31, 2024
- Completion date
- Oct 31, 2024
- First posted
- May 16, 2022
- Last posted
- May 16, 2022
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dasman Diabetes InstituteLead sponsor
- Dasman Diabetes InstituteOverall official - principal investigator
- Dasman Diabetes InstituteReponsible party - principal investigator
- Kappa BioscienceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.